Next-Generation Biomanufacturing Market Outlook Highlights Rapid Growth Fueled by Rising Demand for Vaccines Hormones and Recombinant Proteins

Insight Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Next-Generation Biomanufacturing Market- by Medical Applications (Monoclonal Antibodies, Hormones, Vaccines, Recombinant Proteins and Other Applications), Products (Continuous Upstream Biomanufacturing Products, Single-Use Upstream Biomanufacturing Products and Downstream Biomanufacturing Products), Workflow (Upstream Biomanufacturing and Downstream Biomanufacturing), End-Users (Biopharmaceutical Companies, CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing Organization) and Research Institutions), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."

Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1261

According to the latest research by Insight Analytics, the global Next-Generation Biomanufacturing market was valued at 24.9 Billion in 2024. It is expected to reach 80.0 Billion by the year 2034, with a CAGR of 12.6% during a forecast period of 2025-2034.

The rapid growth of the biopharmaceutical sector is driving expansion in the next-generation biomanufacturing market, which relies heavily on advanced biomanufacturing techniques for the research and production of biologically based products. These next-generation manufacturing processes leverage cutting-edge technologies such as artificial intelligence, machine learning, and augmented reality, delivering outcomes that are more efficient, seamless, and of superior quality compared to traditional first-generation methods.

Key factors anticipated to significantly influence market growth include the presence of well-established healthcare infrastructures, advancements in next-generation bioprocessing units, increasing government support, the rising incidence of genetic and chronic diseases, an aging global population, and the availability of sophisticated medical technologies. Given the complex nature of drug and material discovery and production, which requires specialized tools and processes, biopharmaceutical companies are increasingly adopting advanced biomanufacturing solutions to enhance production efficiency and quality. This trend is expected to drive the expansion of next-generation biomanufacturing products in the coming years. However, market adoption may be constrained by challenges such as a shortage of skilled personnel and the inherent complexity of these advanced manufacturing processes.

Regionally, North America is poised to maintain a leading role in the next-generation biomanufacturing market due to the strong presence of major biopharmaceutical companies, widespread adoption of innovative technologies, and well-developed biological research infrastructure. Similarly, the European market is projected to experience significant growth during the forecast period, supported by the increasing implementation of advanced technologies and growing patient populations in countries such as China and India.

Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04

Major market players operating in the Next-Generation Biomanufacturing market include Applikon Biotechnology BV (Netherlands), bbi-biotech GmbH (Germany), Danaher Corporation (US), Eppendorf AG (Germany), Esco Group of Companies (US), GEA Group Aktiengesellschaft (Germany), Meissner Filtration Products, Inc. (US), Merck KGaA (Germany), PBS Biotech, Inc. (US), Pierre Guérin (France), Sartorius AG (Germany), Shanghai Bailun Biotechnology Co. Ltd. (China), Solaris Biotechnology Srl. (Italy), Thermo Fisher Scientific Inc. (US), ZETA GmbH (Austria), and others.

Recent collaborations and agreements in the market:
In August 2021, PBS Biotech (US) raised its most significant round of funding from BroadOak Capital Partners to develop its product offerings and capabilities. The funds will be utilized to increase PBS's product offerings and capabilities and address the demand for cell therapies.
In February 2021, Merck (Germany) collaborated with Alteogen, Inc. (South Korea), which provides late-stage CDMO services via Merck's BioReliance end-to-end solutions. Alteogen chose Merck to develop and manufacture recombinant biologics for developing and clinical testing next-generation monoclonal antibody medicines.

Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/1261

Market Segments
Global Next-Generation Biomanufacturing Market, by Medical Applications, 2022-2030 (Value US$ Mn)
• Monoclonal Antibodies
• Hormones
• Vaccines
• Recombinant Proteins
• Other Applications
Global Next-Generation Biomanufacturing Market, by Products, 2022-2030 (Value US$ Mn)
• Continuous Upstream Biomanufacturing Products
• Single-Use Upstream Biomanufacturing Products
• Downstream Biomanufacturing Products
Global Next-Generation Biomanufacturing Market, by Workflow, 2022-2030 (Value US$ Mn)
• Upstream Biomanufacturing
• Downstream Biomanufacturing
Global Next-Generation Biomanufacturing Market, by End-Users, 2022-2030 (Value US$ Mn)
• Biopharmaceutical Companies
• CMOs (Contract manufacturing organizations)/CDMOs (Contract Development and Manufacturing organizations)
• Research Institutions
Global Next-Generation Biomanufacturing Market, by Region, 2022-2030 (Value US$ Mn)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• U.S.
• Canada
Europe Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Next-Generation Biomanufacturing Market, by Country, 2022-2030 (Value US$ Mn)
• GCC Countries
• South Africa
• Rest of Middle East & Africa

Why should buy this report:
 To receive a comprehensive analysis of the prospects for the global Next-Generation Biomanufacturing market
 To receive an industry overview and future trends in the Next-Generation Biomanufacturing market
 To analyze the Next-Generation Biomanufacturing market drivers and challenges
 To get information on the Next-Generation Biomanufacturing market value (US$Mn) forecast to 2030
 Significant investments, mergers & acquisitions in the Next-Generation Biomanufacturing market industry

Read Overview Report- https://www.insightaceanalytic.com/report/global-next-generation-biomanufacturing-market-/1261

About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com

This release was published on openPR.